ConductScience.org, home

Paper24782871

How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Haabeth OA and 10 others. Front Immunol, 2014. Cited by 161 papers, by iCite.

Cite this record

ConductScience Library. How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? Papers, record 24782871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24782871

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
PubMed
Journal
Front Immunol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
161
iCite
Relative citation ratio, by iCite
4.1
iCite
Revised in PubMed
2022-03-16
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Haabeth OAOle Audun Werner
2Tveita AAAnders Aune
3Fauskanger MMarte
4Schjesvold FFredrik
5Lorvik KBKristina Berg
6Hofgaard POPeter O
7Omholt HHilde
8Munthe LALudvig A
9Dembic ZZlatko
10Corthay AAlexandre
11Bogen BBjarne

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116179369Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.Blood2006https://conductscience.org/library/papers/16179369PubMed
24177521Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.Biochemistry1968https://conductscience.org/library/papers/4177521PubMed
37931066Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.J Exp Med1994https://conductscience.org/library/papers/7931066PubMed
410411927CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10411927PubMed
53096740Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules.Eur J Immunol1986https://conductscience.org/library/papers/3096740PubMed
610894167CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.Immunity2000https://conductscience.org/library/papers/10894167PubMed
710981969Eradication of established tumors by CD8+ T cell adoptive immunotherapy.Immunity2000https://conductscience.org/library/papers/10981969PubMed
822383793Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice.Blood2012https://conductscience.org/library/papers/22383793PubMed
918026089Adaptive immunity maintains occult cancer in an equilibrium state.Nature2007https://conductscience.org/library/papers/18026089PubMed
1012407407Natural selection of tumor variants in the generation of "tumor escape" phenotypes.Nat Immunol2002https://conductscience.org/library/papers/12407407PubMed
114921480The concept of immunological surveillance.Prog Exp Tumor Res1970https://conductscience.org/library/papers/4921480PubMed
1212242449Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.Science2002https://conductscience.org/library/papers/12242449PubMed
1323933259Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.Cell Rep2013https://conductscience.org/library/papers/23933259PubMed
1420178101"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.Int J Cancer2010https://conductscience.org/library/papers/20178101PubMed
151900037Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression.Cancer Res1991https://conductscience.org/library/papers/1900037PubMed
179553774Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.Immunol Cell Biol1998https://conductscience.org/library/papers/9553774PubMed
186749856The signal sequence of ovalbumin is located near the NH2 terminus.J Biol Chem1982https://conductscience.org/library/papers/6749856PubMed
1922318521Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.Nature2012https://conductscience.org/library/papers/22318521PubMed
206208035Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognate vs. noncognate interactions in cytolysis.Eur J Immunol1984https://conductscience.org/library/papers/6208035PubMed
218016643Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.Science1994https://conductscience.org/library/papers/8016643PubMed

See all 102 referencesDownload CSV of references

Cited by115

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.

PMIDTitleJournalYearIn PapersSource
42027953Molecular origin, discovery, validation and application of neoantigens.Asian J Pharm Sci2026https://conductscience.org/library/papers/42027953PubMed
41836358Crosstalk between autophagy and apoptosis in initiating antitumor immune responses in human lymphoma cells.Explor Immunol2025https://conductscience.org/library/papers/41836358PubMed
41834910Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis.EXCLI J2026https://conductscience.org/library/papers/41834910PubMed
41659739Mendelian Randomization Combined with Bioinformatics Revealed Specific Allergy-Mediated Protective Mechanisms Against Renal Cell Carcinoma.Phenomics2025https://conductscience.org/library/papers/41659739PubMed
40804146In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy.Cell Biochem Biophys2025https://conductscience.org/library/papers/40804146PubMed
40746387Protective and Susceptibility Effects of Human Leukocyte Antigen on Melanoma Prevalence and their Implications for Predicting Checkpoint Blockade Immunotherapy Outcomes.J Immunol Sci2022https://conductscience.org/library/papers/40746387PubMed
40379687Asterias amurensis lipids enhance the immunity of immunosuppressed mice as sustainable marine-eco materials.Sci Rep2025https://conductscience.org/library/papers/40379687PubMed
40281615Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO2 and carbon black.Part Fibre Toxicol2025https://conductscience.org/library/papers/40281615PubMed
40248717Closer proximity of pre-treatment CD4+ T cells to CD8+ T cells favor response to neoadjuvant immunotherapy in patients with PD-L1 low-expressing non-small cell lung cancer.Transl Lung Cancer Res2025https://conductscience.org/library/papers/40248717PubMed
40129873DNA-PKcs Dysfunction Enhances the Antitumor Activity of Radioimmunotherapy by Activating the cGAS-STING Pathway in HNSCC.J Inflamm Res2025https://conductscience.org/library/papers/40129873PubMed
39720956Cancer vaccines: an update on recent achievements and prospects for cancer therapy.Clin Exp Med2024https://conductscience.org/library/papers/39720956PubMed
39673127Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal.Mol Ther2025https://conductscience.org/library/papers/39673127PubMed
39106430Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis.PLoS One2024https://conductscience.org/library/papers/39106430PubMed
39086686Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors.Front Mol Med2023https://conductscience.org/library/papers/39086686PubMed
39039195Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model.Cancer Gene Ther2024https://conductscience.org/library/papers/39039195PubMed
38920557Antimelanoma Effects of Alchemilla vulgaris: A Comprehensive In Vitro and In Vivo Study.Diseases2024https://conductscience.org/library/papers/38920557PubMed
38545119Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy.Front Immunol2024https://conductscience.org/library/papers/38545119PubMed
38287290Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.BMC Cancer2024https://conductscience.org/library/papers/38287290PubMed
38146419Retrospective Analysis of the Clinical Characteristics of Patients with Breast Cancer Treated with Telomerase Peptide Immunotherapy Combined with Cytotoxic Chemotherapy.Breast Cancer (Dove Med Press)2023https://conductscience.org/library/papers/38146419PubMed
37671471A Wrinkle in TIME: How Changes in the Aging ECM Drive the Remodeling of the Tumor Immune Microenvironment.Cancer Discov2023https://conductscience.org/library/papers/37671471PubMed

See all 115 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24782871

GET https://conductscience.org/api/papers/v1/24782871/references?page=2